1323919-50-1

Downstream Products

• 1353967-40-4 8-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-quinazolin-4-ylamine 
• 1353968-20-3 2-(2-fluoro-phenyl)-4-[5-(1-methyl-1H-pyrazol-4-yl)-isoquinolin-8-yl]-[1,8]naphthyridine 
• 1353967-88-0 2-(2-fluoro-phenyl)-4-(4-methoxy-[2,6]naphthyridin-1-yl)-[1,8]naphthyridine 
• 1353970-49-6 4-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-[1,7]naphthyridine 7-oxide 
• 1353967-68-6 1-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-4-methoxy-pyrido[3,4-d]pyridazine 
• 1353970-11-2 2-(2-fluoro-phenyl)-4-(8-nitro-2-oxy-isoquinolin-5-yl)-[1,8]naphthyridine 
• 1353967-72-2 8-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-pyrido[3,4-d]pyrimidin-4-ylamine 
• 1353970-08-7 3-amino-2-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-isonicotinonitrile 
• 1353968-69-0 2-(2-fluoro-phenyl)-4-(6-oxy-[2,6]naphthyridin-1-yl)-[1,8]naphthyridine 
• 1353969-30-8 4-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-[1,7]naphthyridine 
• 1353967-97-1 2-(2-fluoro-phenyl)-4-[8-(1-methyl-1H-pyrazol-4-yl)-isoquinolin-5-yl]-[1,8]naphthyridine 
• 1353967-45-9 4-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-pyrido[3,4-d]pyrimidine 
• 1353970-19-0 2-amino-3-[2-(2-fluoro-phenyl)-[1,8]naphthyridin-4-yl]-benzonitrile 
• 1323920-13-3 C₂₂H₁₃FN₄O 

Relevant academic research and scientific papers

2,4-DIARYL - SUBSTITUTED [1,8] NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER

The present invention relates to novel [1,8]naphthyridine derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases plays a role, particu

2,4- DIARYL-SUBSTITUTED [1,8] NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER

The present invention relates to novel [1,8]naphthyridine derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases playsa role, particularly to inhibitors of TGF-beta receptor kinases, and to the use of such compounds for the treatment of kinase-induced diseases, in particular for the treatment of tumors

Hetaryl-[1,8]naphthyridine derivatives

Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R1, R2, W1, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.

HETARYL-[1,8]NAPHTHYRIDINE DERIVATIVES

Novel hetaryl-[1,8]naphthyridine derivatives of formula (I) wherein R1, R2, W1, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.